New Rhein Healthcare Investors

Founded in 2010, New Rhein is a private equity investment firm focused on healthcare therapeutics and medical devices. The firm invests in businesses which utilize proven products in new applications (e.g., new indications, new dosage forms). Products can either be patent protected and branded, non-patent protected and branded, or non-patent protected and non-branded. Companies should generate at least $5M to $50M in revenues and $1M to $10M in operating profit. New Rhein prefers to invest in companies based in Europe, United States, Brazil, and China.